Your browser doesn't support javascript.
loading
Phase IIIb safety results from an expanded-access protocol of talimogene laherparepvec for patients with unresected, stage IIIB-IVM1c melanoma.
Chesney, Jason; Awasthi, Sanjay; Curti, Brendan; Hutchins, Laura; Linette, Gerald; Triozzi, Pierre; Tan, Marcus C B; Brown, Russell E; Nemunaitis, John; Whitman, Eric; Windham, Christopher; Lutzky, Jose; Downey, Gerald F; Batty, Nicolas; Amatruda, Thomas.
Afiliação
  • Chesney J; Department of Medicine, University of Louisville, Louisville, Kentucky.
  • Awasthi S; Department of Medical Oncology, City of Hope, Duarte.
  • Curti B; Earle A Chiles Research Institute, Providence Cancer Center, Portland, Oregon.
  • Hutchins L; Department of Internal Medicine, Division of Hematology Oncology, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
  • Linette G; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Triozzi P; Section of Hematology and Oncology, Wake Forest School of Medicine, Winston-Salem.
  • Tan MCB; Division of Surgical Oncology, University of South Alabama, Mobile, Alabama.
  • Brown RE; Department of Surgery, Ochsner Medical Center, New Orleans, Louisiana.
  • Nemunaitis J; Department of Medical Hematology and Oncology, Mary Crowley Cancer Research Center, Dallas, Texas.
  • Whitman E; Department of Endocrine and Oncologic Surgery, Atlantic Melanoma Center, Atlantic Health System Cancer Care, Morristown, New Jersey.
  • Windham C; Department of Oncology, Cone Health, Greensboro, North Carolina.
  • Lutzky J; Division of Hematology and Oncology, Mount Sinai Medical Center, Miami Beach, Florida.
  • Downey GF; Center for Design and Analysis, Amgen Limited, Cambridge, UK.
  • Batty N; Department of Clinical Research, Amgen Inc., Thousand Oaks, California.
  • Amatruda T; Department of Hematology and Oncology, Minnesota Oncology, Fridley, Minnesota.
Melanoma Res ; 28(1): 44-51, 2018 02.
Article em En | MEDLINE | ID: mdl-29176501

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Viral Oncolítica / Melanoma Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Melanoma Res Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Viral Oncolítica / Melanoma Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Melanoma Res Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article